Article

Radiopharmaceuticals: new antimicrobial agents.

Department of Infectious Diseases, Leiden University Medical Center, Leiden, The Netherlands.
Trends in Biotechnology (Impact Factor: 10.04). 03/2003; 21(2):70-3. DOI: 10.1016/S0167-7799(02)00032-X
Source: PubMed

ABSTRACT Small antimicrobial peptides are good candidates for new antimicrobial agents. A scintigraphic approach to studying the pharmacokinetics of antimicrobial peptides in animals has been developed. The peptides were safely and reproducibly labelled with technetium-99m and, after intravenous injection of the radiolabelled peptides into infected animals, scintigraphy allowed real-time quantification of the peptide in the various body compartments. Antimicrobial peptides rapidly accumulated at sites of infection but not at sites of sterile inflammation, indicating that radiolabelled antimicrobial peptides could be used in detection of infection. These radiopharmaceuticals enabled the efficacy of antibacterial therapy in animals to be monitored. The scintigraphic approach provides a useful method for investigating the pharmacokinetics of small peptides in animals.

Download full-text

Full-text

Available from: Antonella Lupetti, Jun 20, 2015
0 Followers
 · 
90 Views
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: The presence and antimicrobial activity of antimicrobial peptides (AMPs) has been widely recognized as an evolutionary preserved part of the innate immune system. Based on evidence in animal models and humans, AMPs are now positioned as novel anti-infective agents. The current study aimed to evaluate the potential antimicrobial activity of ubiquicidin and small synthetic fragments thereof towards methicillin resistant Staphylococcus aureus (MRSA), as a high priority target for novel antibiotics. In vitro killing of MRSA by synthetic peptides derived from the alpha-helix or beta-sheet domains of the human cationic peptide ubiquicidin (UBI 1-59), allowed selection of AMPs for possible treatment of MRSA infections. The strongest antibacterial activity was observed for the entire peptide UBI 1-59 and for synthetic fragments comprising amino acids 31-38. The availability, chemical synthesis opportunities, and size of these small peptides, combined with their strong antimicrobial activity towards MRSA make these compounds promising candidates for antimicrobial therapy and detection of infections in man.
    Peptides 12/2006; 27(11):2585-91. DOI:10.1016/j.peptides.2006.05.022 · 2.61 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: The first chapter introduces the main concepts of this manuscript: osteomyelitis (bone infection), bacterial resistance and antimicrobial peptides (AMPs). As part of a solution to the first two problems, AMPs were investigated for the experimental prevention of infection. The first chapter introduces several AMPs which have been investigated in pre-clinical studies. In our experiments hLF1-11 was used, it consists of amino acids one to eleven of human lactoferrin. We investigated a biodegradable carrier-system for local treatment or prevention of bone infection. The properties of several biodegradable carriers were investigated in chapters two and three. The chapters show the release profiles of hLF1- 11 and gentamicin, a conventional antibiotic, from a dozen different carrier materials. The activity on bacterial strains was confirmed after the release process. Chapter four describes the toxic properties and antimicrobial spectrum of hLF1-11 and control peptides. No specific toxicity was observed on blood and bone cells. The peptide rapidly killed all clinically problematic bacterial strains. These results encouraged us to set up several animal experiments. For these experiments a combination of biodegradable cement (Bonesource) and hLF1-11 was selected. In the rabbit experiments, the release of hLF1-11 from calcium phosphate cement was used as a prophylactic agent against infection with Staphylococcus aureus, the principal cause of osteomyelitis. Chapter five describes the release of hLF1-11 from cement into bone, the AMP rapidly dissipated from the carrier. This was comparable to the earlier in vitro experiments (chapters two and three). Chapter six combines all results from earlier chapters in a prevention study. The rabbits were surgically contaminated with S. aureus and injected with cement and hLF1-11. After removal and culture of the bones, a significant reduction of infection was measured by both hLF1-11 and (standard) gentamicin. This confirms the clinical potential in local treatment of infection. Study aims - To develop a biodegradable carrier for release of hLF1-11. - To evaluate the cytotoxicity and antimicrobial efficacy of hLF1-11. - To compare the results to gentamicin and other antimicrobial peptides for reference. - To implant the carrier and the peptide in an animal model and study its release end efficacy.
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Nuclear medicine imaging techniques offer whole body imaging for localization of number and site of infective foci inspite of limitation of spatial resolution. The innate human immune system contains a large member of important elements including antimicrobial peptides to combat any form of infection. However, development of antibiotics against bacteria progressed rapidly and gained popularity over antimicrobial peptides but even powerful antimicrobials failed to reduce morbidity and mortality due to emergence of mutant strains of bacteria resulting in antimicrobial resistance. Differentiation between infection and inflammation using radiolabeled compounds with nuclear medicine techniques has always been a dilemma which is still to be resolved. Starting from nonspecific tracers to specific radiolabeled tracers, the question is still unanswered. Specific radiolabeled tracers included antibiotics and antimicrobial peptides which bind directly to the bacteria for efficient localization with advanced nuclear medicine equipments. However, there are merits and demerits attributed to each. In the current paper, radiolabeled antibiotics and radiolabeled peptides for infection localization have been discussed starting with the background of primitive nonspecific tracers. Radiolabeled antimicrobial peptides have certain merits compared with labeled antibiotics which make them superior agents for localization of infective focus.
    International Journal of Peptides 05/2012; 2012:965238. DOI:10.1155/2012/965238